GlassScriptPhysician profile
Ricardo Lopez
NPI 1720739568
$4,223.41
in general payments reported to CMS, 2019-2025
14 companies · $69.27 in 2025
The $69.27 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.28 · 2023: $1,960 · 2024: $2,114 · 2025: $69.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,529 · Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,528.87 |
| Food and Beverage | $1,614.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,767.06 | 2024 | |
| Modernatx, INC. | $1,723.99 | 2023 | |
| Abbvie INC. | $123.83 | 2024-2025 | |
| Eisai INC. | $121.41 | 2023 | |
| Gilead Sciences, INC. | $120.81 | 2024 | Livdelzi |
| Cardiva Medical, INC. | $80.28 | 2022 | |
| Madrigal Pharmaceuticals | $79.45 | 2024-2025 | Rezdiffra, Resmetirom |
| Takeda Pharmaceuticals U.S.A., INC. | $58.07 | 2024 | Entyvio |
| Intra-Sana Laboratories | $50.00 | 2023 | Reltone 200 Mg, Reltone 400 Mg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.30 | 2024 | Xifaxan |
| Siemens Medical Solutions USA, INC. | $19.04 | 2023 | Biograph Mct X-4r |
| Exact Sciences Corporation | $17.65 | 2023 | |
| Travere Therapeutics, INC. | $13.94 | 2023 | Cholbam |
| Intercept Pharmaceuticals, INC. | $13.58 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.